Search News Posts
General Inquiries 1-888-555-5555
•
Support 1-888-555-5555
Gene Expression Analysis
In this case study, we will explore how data analytics was used to understand gene expression patterns in cancer patients. Cancer is a complex disease that arises from genetic mutations and alterations in gene expression patterns. By analyzing gene expression data, we can identify specific genes and pathways that are dysregulated in cancer cells, which can be targeted for therapy.
Gene expression analysis is a powerful tool that helps to understand the underlying biological mechanisms of disease progression. By analyzing gene expression data, we can identify specific genes and pathways that are dysregulated in cancer cells, which can be targeted for therapy.
The dataset used in this study was obtained from The Cancer Genome Atlas (TCGA) project. The dataset contained gene expression data from 500 cancer patients and 100 healthy individuals. The goal of this study was to identify differentially expressed genes (DEGs) in cancer patients and to understand the biological processes that were affected by these DEGs.
Sample
Gene 1
Gene 2
Gene 3
...
Gene n
1
0.20
0.98
3.14
...
2.34
2
0.92
1.23
3.14
...
1.98
3
1.45
0.87
3.01
...
2.56
....
....
....
....
....
...
600
0.89
1.34
3.05
...
1.78
The gene expression data was preprocessed and normalized using the R programming language. Differential gene expression analysis was performed using the edgeR package. The DEGs were identified using a threshold of log2 fold change > 2 and p-value < 0.05. The DEGs were further analyzed using gene ontology (GO) and pathway enrichment analysis.
At the end we will find these spesific genes that affects, no we will find those spesific genes.
Upregulated Genes
Downregulated Genes
GENE1
GENE2
GENE3
GENE4
GENE5
GENE6
GENE7
GENE8
GENE9
GENE10
The analysis identified a total of 1000 DEGs in cancer patients compared to healthy individuals. The top 10 upregulated and downregulated genes are shown in table below.
Table shows Top 10 upregulated and downregulated genes in cancer patients compared to healthy individuals.
Upregulated Genes
Downregulated Genes
TSPAN8
MUC16
CLDN3
FBN1
IL6ST
CYP2E1
FABP4
MSLN
BIRC5
CYP4B1
PTN
RARRES1
S100P
NR2F1
KRT7
LCN2
KRT19
GPX3
ANXA4
PAPSS2
GO analysis revealed that the upregulated genes were mainly involved in cell proliferation, cell cycle regulation, and DNA repair, while the downregulated genes were involved in immune response and cell adhesion. Pathway analysis showed that the upregulated genes were enriched in the PI3K-Akt signaling pathway, while the downregulated genes were enriched in the ECM-receptor interaction pathway.
This case study demonstrates the power of data analytics in understanding gene expression patterns in cancer patients. The analysis identified several DEGs that were involved in cancer progression and provided insights into the biological processes and pathways that were affected by these DEGs. This information can be used to develop targeted therapies for cancer patients and to identify biomarkers for early detection of cancer. Further research is needed to validate these findings and to explore the potential clinical applications of this approach.
Are you looking to create a lasting impact with your data analytics? Contact us to create them in hours.